10-Q 1 abt-20220630.htm 10-Q abt-20220630
000000180012-312022Q2falseP12M00000018002022-01-012022-06-300000001800exch:XNYS2022-01-012022-06-300000001800exch:XCHI2022-01-012022-06-3000000018002022-06-30xbrli:shares00000018002022-04-012022-06-30iso4217:USD00000018002021-04-012021-06-3000000018002021-01-012021-06-30iso4217:USDxbrli:shares00000018002021-12-310000001800us-gaap:CommonStockMember2022-03-310000001800us-gaap:CommonStockMember2021-03-310000001800us-gaap:CommonStockMember2022-04-012022-06-300000001800us-gaap:CommonStockMember2021-04-012021-06-300000001800us-gaap:CommonStockMember2022-06-300000001800us-gaap:CommonStockMember2021-06-300000001800us-gaap:TreasuryStockCommonMember2022-03-310000001800us-gaap:TreasuryStockCommonMember2021-03-310000001800us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000001800us-gaap:TreasuryStockCommonMember2021-04-012021-06-300000001800us-gaap:TreasuryStockCommonMember2022-06-300000001800us-gaap:TreasuryStockCommonMember2021-06-300000001800us-gaap:RetainedEarningsMember2022-03-310000001800us-gaap:RetainedEarningsMember2021-03-310000001800us-gaap:RetainedEarningsMember2022-04-012022-06-300000001800us-gaap:RetainedEarningsMember2021-04-012021-06-300000001800us-gaap:RetainedEarningsMember2022-06-300000001800us-gaap:RetainedEarningsMember2021-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000001800us-gaap:NoncontrollingInterestMember2022-03-310000001800us-gaap:NoncontrollingInterestMember2021-03-310000001800us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000001800us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000001800us-gaap:NoncontrollingInterestMember2022-06-300000001800us-gaap:NoncontrollingInterestMember2021-06-300000001800us-gaap:CommonStockMember2021-12-310000001800us-gaap:CommonStockMember2020-12-310000001800us-gaap:CommonStockMember2022-01-012022-06-300000001800us-gaap:CommonStockMember2021-01-012021-06-300000001800us-gaap:TreasuryStockCommonMember2021-12-310000001800us-gaap:TreasuryStockCommonMember2020-12-310000001800us-gaap:TreasuryStockCommonMember2022-01-012022-06-300000001800us-gaap:TreasuryStockCommonMember2021-01-012021-06-300000001800us-gaap:RetainedEarningsMember2021-12-310000001800us-gaap:RetainedEarningsMember2020-12-310000001800us-gaap:RetainedEarningsMember2022-01-012022-06-300000001800us-gaap:RetainedEarningsMember2021-01-012021-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300000001800us-gaap:NoncontrollingInterestMember2021-12-310000001800us-gaap:NoncontrollingInterestMember2020-12-310000001800us-gaap:NoncontrollingInterestMember2022-01-012022-06-300000001800us-gaap:NoncontrollingInterestMember2021-01-012021-06-3000000018002020-12-3100000018002021-06-30abt:segment0000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:USabt:KeyEmergingMarketsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberabt:KeyEmergingMarketsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:USabt:KeyEmergingMarketsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberabt:KeyEmergingMarketsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMembercountry:US2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMembercountry:US2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:US2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:US2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2022-04-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2021-04-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMembercountry:USabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMembercountry:USabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:USabt:CoreLaboratoryMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:USabt:CoreLaboratoryMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2021-04-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-04-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-04-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-04-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-04-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-04-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-04-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-04-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-04-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-04-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2021-04-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-04-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-04-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-04-012021-06-300000001800us-gaap:CorporateNonSegmentMembercountry:US2022-04-012022-06-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2022-04-012022-06-300000001800us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000001800us-gaap:CorporateNonSegmentMembercountry:US2021-04-012021-06-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2021-04-012021-06-300000001800us-gaap:CorporateNonSegmentMember2021-04-012021-06-300000001800country:US2022-04-012022-06-300000001800us-gaap:NonUsMember2022-04-012022-06-300000001800country:US2021-04-012021-06-300000001800us-gaap:NonUsMember2021-04-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:USabt:KeyEmergingMarketsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberabt:KeyEmergingMarketsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:USabt:KeyEmergingMarketsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberabt:KeyEmergingMarketsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMembercountry:US2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMembercountry:US2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberabt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:US2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMembercountry:US2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2022-01-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2021-01-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800abt:PediatricNutritionalsMemberus-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMembercountry:USabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMembercountry:USabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMembercountry:USabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:NutritionalProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:USabt:CoreLaboratoryMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:USabt:CoreLaboratoryMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:CoreLaboratoryMember2021-01-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-01-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-01-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:MolecularMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-01-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-01-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:PointOfCareMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-01-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-01-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-01-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-01-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800abt:RhythmManagementMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:HeartFailureMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:VascularProductsMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:StructuralHeartMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMemberabt:NeuromodulationMember2021-01-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-01-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-01-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800abt:DiabetesCareMemberus-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMembercountry:US2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:OperatingSegmentsMemberabt:MedicalDevicesMember2021-01-012021-06-300000001800us-gaap:CorporateNonSegmentMembercountry:US2022-01-012022-06-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2022-01-012022-06-300000001800us-gaap:CorporateNonSegmentMember2022-01-012022-06-300000001800us-gaap:CorporateNonSegmentMembercountry:US2021-01-012021-06-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2021-01-012021-06-300000001800us-gaap:CorporateNonSegmentMember2021-01-012021-06-300000001800country:US2022-01-012022-06-300000001800us-gaap:NonUsMember2022-01-012022-06-300000001800country:US2021-01-012021-06-300000001800us-gaap:NonUsMember2021-01-012021-06-300000001800abt:DiagnosticProductsMember2022-06-300000001800abt:MedicalDevicesMember2022-06-3000000018002022-07-012022-01-012022-06-30xbrli:pure00000018002022-07-012022-06-3000000018002024-07-012022-01-012022-06-3000000018002024-07-012022-06-300000001800us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-06-300000001800us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-06-300000001800us-gaap:EquitySecuritiesMember2022-06-300000001800us-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:OtherInvestmentsMember2022-06-300000001800us-gaap:OtherInvestmentsMember2021-12-310000001800abt:StJudeMedicalInc.Memberus-gaap:EquitySecuritiesMember2022-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-03-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-012022-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-012021-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-012021-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-06-300000001800abt:EstablishedPharmaceuticalProductsMember2022-06-300000001800abt:NutritionalProductsMember2022-06-300000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-04-012021-06-300000001800abt:FixedAssetWriteDownsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-04-012021-06-300000001800abt:InventoryRelatedChargesMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-04-012021-06-300000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-04-012021-06-300000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-07-012021-12-310000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-07-012021-12-310000001800abt:InventoryRelatedChargesMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-01-012021-12-310000001800abt:FixedAssetWriteDownsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-01-012021-12-310000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-01-012021-12-310000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-01-012021-12-310000001800abt:InventoryRelatedChargesMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-12-310000001800abt:FixedAssetWriteDownsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-12-310000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-12-310000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2021-12-310000001800abt:InventoryRelatedChargesMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-01-012022-06-300000001800abt:FixedAssetWriteDownsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-01-012022-06-300000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-01-012022-06-300000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-01-012022-06-300000001800abt:InventoryRelatedChargesMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-06-300000001800abt:FixedAssetWriteDownsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-06-300000001800abt:OtherExitCostsMemberabt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-06-300000001800abt:Covid19TestManufacturingNetworkRestructuringPlanMember2022-06-300000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-01-012021-12-310000001800us-gaap:CostOfSalesMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-01-012021-12-310000001800us-gaap:ResearchAndDevelopmentExpenseMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-01-012021-12-310000001800us-gaap:SellingGeneralAndAdministrativeExpensesMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-01-012021-12-310000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-12-310000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-01-012022-06-300000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-06-300000001800us-gaap:EmployeeStockOptionMember2022-01-012022-06-300000001800abt:RestrictedStockAwardsMember2022-01-012022-06-300000001800us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300000001800us-gaap:EmployeeStockOptionMember2022-06-300000001800abt:A255LongTermNotesDue2022Member2022-03-152022-03-150000001800abt:A255LongTermNotesDue2022Member2022-03-150000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-12-310000001800us-gaap:DesignatedAsHedgingInstrumentMemberabt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-12-310000001800us-gaap:DesignatedAsHedgingInstrumentMemberabt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberabt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMember2022-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberabt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMember2021-12-310000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-12-310000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberabt:DeferredIncomeTaxesAndOtherAssetsMemberus-gaap:InterestRateSwapMember2022-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberabt:DeferredIncomeTaxesAndOtherAssetsMemberus-gaap:InterestRateSwapMember2021-12-310000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberabt:PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMemberus-gaap:InterestRateSwapMember2022-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberabt:PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMemberus-gaap:InterestRateSwapMember2021-12-310000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-06-300000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2021-12-310000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-06-300000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-12-310000001800us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2021-12-310000001800us-gaap:LongTermDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2022-06-300000001800us-gaap:LongTermDebtMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2021-12-310000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2022-04-012022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2021-04-012021-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2022-01-012022-06-300000001800us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2021-01-012021-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2022-04-012022-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2021-04-012021-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-06-300000001800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2022-04-012022-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2021-04-012021-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2022-01-012022-06-300000001800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2021-01-012021-06-300000001800us-gaap:ForeignExchangeForwardMember2022-04-012022-06-300000001800us-gaap:ForeignExchangeForwardMember2021-04-012021-06-300000001800us-gaap:ForeignExchangeForwardMember2022-01-012022-06-300000001800us-gaap:ForeignExchangeForwardMember2021-01-012021-06-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-06-300000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-06-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000001800us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300000001800us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000001800us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000001800us-gaap:FairValueMeasurementsRecurringMember2022-06-300000001800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000001800us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000001800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000001800us-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800abt:LegalProceedingsAndEnvironmentalExposuresMembersrt:MinimumMember2022-06-300000001800abt:LegalProceedingsAndEnvironmentalExposuresMembersrt:MaximumMember2022-06-300000001800abt:LegalProceedingsAndEnvironmentalExposuresMember2022-06-300000001800us-gaap:PensionPlansDefinedBenefitMember2022-04-012022-06-300000001800us-gaap:PensionPlansDefinedBenefitMember2021-04-012021-06-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-04-012022-06-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-04-012021-06-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-06-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-06-300000001800srt:MinimumMember2022-06-300000001800srt:MaximumMember2022-06-300000001800us-gaap:OperatingSegmentsMember2022-04-012022-06-300000001800us-gaap:OperatingSegmentsMember2021-04-012021-06-300000001800us-gaap:OperatingSegmentsMember2022-01-012022-06-300000001800us-gaap:OperatingSegmentsMember2021-01-012021-06-300000001800us-gaap:MaterialReconcilingItemsMember2022-04-012022-06-300000001800us-gaap:MaterialReconcilingItemsMember2021-04-012021-06-300000001800us-gaap:MaterialReconcilingItemsMember2022-01-012022-06-300000001800us-gaap:MaterialReconcilingItemsMember2021-01-012021-06-300000001800abt:NutritionalProductsMember2022-04-012022-06-300000001800abt:NutritionalProductsMember2022-01-012022-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to
Commission File No. 1-2189
ABBOTT LABORATORIES
An Illinois Corporation
I.R.S. Employer Identification No.
36-0698440
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
Telephone: (224) 667-6100
Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Shares, Without Par ValueABT
New York Stock Exchange
Chicago Stock Exchange, Inc.
Indicate by check mark whether the registrant: (l) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of l934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer x
Accelerated Filer o
Non-Accelerated Filer o
Smaller reporting company o
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of June 30, 2022, Abbott Laboratories had 1,751,219,743 common shares without par value outstanding.


Abbott Laboratories
Table of Contents
2



Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited)
(dollars in millions except per share data; shares in thousands)
Three Months Ended Six Months Ended
June 30June 30
2022202120222021
Net sales$11,257 $10,223 $23,152 $20,679 
Cost of products sold, excluding amortization of intangible assets4,933 4,947 9,920 9,348 
Amortization of intangible assets507 504 1,019 1,013 
Research and development684 654 1,381 1,308 
Selling, general and administrative2,757 2,726 5,544 5,509 
Total operating cost and expenses8,881 8,831 17,864 17,178 
Operating earnings2,376 1,392 5,288 3,501 
Interest expense132 134 263 269 
Interest (income)(26)(11)(40)(22)
Net foreign exchange (gain) loss  (3)3 
Other (income) expense, net(82)(79)(160)(140)
Earnings before taxes2,352 1,348 5,228 3,391 
Taxes on earnings334 159 763 409 
Net Earnings$2,018 $1,189 $4,465 $2,982 
Basic Earnings Per Common Share$1.15 $0.67 $2.53 $1.67 
Diluted Earnings Per Common Share$1.14 $0.66 $2.51 $1.66 
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share1,753,865 1,779,203 1,757,858 1,778,049 
Dilutive Common Stock Options11,598 14,076 12,115 14,369 
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options1,765,463 1,793,279 1,769,973 1,792,418 
Outstanding Common Stock Options Having No Dilutive Effect5,419 2,720 2,655 2,694 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
3

Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Comprehensive Income
(Unaudited)
(dollars in millions)
Three Months EndedSix Months Ended
June 30June 30
2022202120222021
Net Earnings$2,018 $1,189 $4,465 $2,982 
Foreign currency translation gain (loss) adjustments(315)165 (421)(371)
Net actuarial gains (losses) and amortization of net actuarial losses and prior service costs and credits, net of taxes of $12 and $25 in 2022 and $18 and $36 in 2021
54 48 116 133 
Net gains (losses) for derivative instruments designated as cash flow hedges and other, net of taxes of $61 and $46 in 2022 and $2 and $48 in 2021
29 6 (27)118 
Other comprehensive income (loss)(232)219 (332)(120)
Comprehensive Income$1,786 $1,408 $4,133 $2,862 
June 30,
2022
December 31,
2021
Supplemental Accumulated Other Comprehensive Income (Loss) Information, net of tax:
Cumulative foreign currency translation (loss) adjustments$(6,260)$(5,839)
Net actuarial (losses) and prior service (costs) and credits(2,554)(2,670)
Cumulative gains (losses) on derivative instruments designated as cash flow hedges and other108 135 
Accumulated other comprehensive income (loss)$(8,706)$(8,374)
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
4

Abbott Laboratories and Subsidiaries
Condensed Consolidated Balance Sheet
(Unaudited)
(dollars in millions)
June 30,
2022
December 31,
2021
Assets
Current Assets:
Cash and cash equivalents$8,937 $9,799 
Short-term investments353 450 
Trade receivables, less allowances of $572 in 2022 and $519 in 2021
7,199 6,487 
Inventories:
Finished products3,570 3,081 
Work in process710 694 
Materials1,619 1,382 
Total inventories5,899 5,157 
Prepaid expenses and other receivables2,568 2,346 
Total Current Assets24,956 24,239 
Investments734 816 
Property and equipment, at cost19,458 19,364 
Less: accumulated depreciation and amortization10,640 10,405 
Net property and equipment8,818 8,959 
Intangible assets, net of amortization11,592 12,739 
Goodwill22,744 23,231 
Deferred income taxes and other assets5,358 5,212 
$74,202 $75,196 
Liabilities and Shareholders’ Investment
Current Liabilities:
Trade accounts payable$4,493 $4,408 
Salaries, wages and commissions1,315 1,625 
Other accrued liabilities5,400 5,181 
Dividends payable824 831 
Income taxes payable355 306 
Current portion of long-term debt5 754 
Total Current Liabilities12,392 13,105 
Long-term debt16,755 17,296 
Post-employment obligations, deferred income taxes and other long-term liabilities8,339 8,771 
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued
  
Common shares, without par value Authorized — 2,400,000,000 shares
Issued at stated capital amount — Shares: 2022: 1,985,676,735; 2021: 1,985,273,421
24,429 24,470 
Common shares held in treasury, at cost — Shares: 2022: 234,456,992; 2021: 221,191,228
(13,720)(11,822)
Earnings employed in the business34,487 31,528 
Accumulated other comprehensive income (loss)(8,706)(8,374)
Total Abbott Shareholders’ Investment36,490 35,802 
Noncontrolling Interests in Subsidiaries226 222 
Total Shareholders’ Investment36,716 36,024 
$74,202 $75,196 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
5

Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Shareholders’ Investment
(Unaudited)
(in millions except shares and per share data)
Three Months Ended June 30
20222021
Common Shares:
Balance at March 31
Shares: 2022: 1,985,525,053; 2021: 1,982,205,491
$24,304 $24,023 
Issued under incentive stock programs  
Shares: 2022: 151,682; 2021: 347,997
10 18 
Share-based compensation125 119 
Issuance of restricted stock awards(10)(7)
Balance at June 30  
Shares: 2022: 1,985,676,735; 2021: 1,982,553,488
$24,429 $24,153 
Common Shares Held in Treasury:
Balance at March 31
Shares: 2022: 234,582,764; 2021: 205,385,343
$(13,726)$(9,845)
Issued under incentive stock programs  
Shares: 2022: 135,663; 2021: 159,644
7 8 
Purchased  
Shares: 2022: 9,891; 2021: 4,510,440
(1)(503)
Balance at June 30  
Shares: 2022: 234,456,992; 2021: 209,736,139
$(13,720)$(10,340)
Earnings Employed in the Business:
Balance at March 31$33,295 $28,669 
Net earnings2,018 1,189 
Cash dividends declared on common shares (per share — 2022: $0.47; 2021: $0.45)
(827)(801)
Effect of common and treasury share transactions1 (4)
Balance at June 30$34,487 $29,053 
Accumulated Other Comprehensive Income (Loss):
Balance at March 31$(8,474)$(9,285)
Other comprehensive income (loss)(232)219 
Balance at June 30$(8,706)$(9,066)
Noncontrolling Interests in Subsidiaries:
Balance at March 31$230 $226 
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases(4)3 
Balance at June 30$226 $229 
The accompanying notes to condensed consolidated financial statements are an integral part of this statement.
6

Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Shareholders’ Investment
(Unaudited)
(in millions except shares and per share data)
Six Months Ended June 30
20222021
Common Shares:
Balance at January 1
Shares: 2022: 1,985,273,421; 2021: 1,981,156,896
$24,470 $24,145 
Issued under incentive stock programs
Shares: 2022: 403,314; 2021: 1,396,592
24 65 
Share-based compensation449 423 
Issuance of restricted stock awards(514)(480)
Balance at June 30
Shares: 2022: 1,985,676,735; 2021: 1,982,553,488
$24,429 $24,153 
Common Shares Held in Treasury:
Balance at January 1
Shares: 2022: 221,191,228; 2021: 209,926,622
$(11,822)$(10,042)
Issued under incentive stock programs
Shares: 2022: 4,280,139; 2021: 4,978,431
230 239 
Purchased
Shares: 2022: 17,545,903; 2021: 4,787,948
(2,128)(537)
Balance at June 30
Shares: 2022: 234,456,992; 2021: 209,736,139
$(13,720)$(10,340)
Earnings Employed in the Business:
Balance at January 1$31,528 $27,627 
Net earnings4,465 2,982 
Cash dividends declared on common shares (per share — 2022: $0.94; 2021: $0.90)
(1,653)(1,604)
Effect of common and treasury share transactions147 48 
Balance at June 30$34,487 $29,053 
Accumulated Other Comprehensive Income (Loss):
Balance at January 1$(8,374)$(8,946)
Other comprehensive income (loss)(332)(120)
Balance at June 30$(8,706)$(9,066)
Noncontrolling Interests in Subsidiaries:
Balance at January 1$222 $219 
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases4 10 
Balance at June 30$226 $229 
The accompanying notes to condensed consolidated financial statements are an integral part of this statement.
7

Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Cash Flows
(Unaudited)
(dollars in millions)
Six Months Ended June 30
20222021
Cash Flow From (Used in) Operating Activities:
Net earnings$4,465 $2,982 
Adjustments to reconcile net earnings to net cash from operating activities —
Depreciation626 795 
Amortization of intangible assets1,019 1,013 
Share-based compensation447 420 
Trade receivables(939)200 
Inventories(1,030)(542)
Other, net(113)(103)
Net Cash From Operating Activities4,475 4,765 
Cash Flow From (Used in) Investing Activities:
Acquisitions of property and equipment(700)(810)
Acquisitions of businesses and technologies, net of cash acquired (15)
Proceeds from business dispositions48 48 
Sales (purchases) of other investment securities, net18 81 
Other10 10 
Net Cash From (Used in) Investing Activities(624)(686)
Cash Flow From (Used in) Financing Activities:
Net borrowings (repayments) of short-term debt and other13 20 
Proceeds from issuance of long-term debt6  
Repayments of long-term debt(752)(5)
Purchases of common shares(2,312)(746)
Proceeds from stock options exercised69 103 
Dividends paid(1,660)(1,603)
Net Cash From (Used in) Financing Activities(4,636)(2,231)
Effect of exchange rate changes on cash and cash equivalents(77)(28)
Net Increase (Decrease) in Cash and Cash Equivalents(862)1,820 
Cash and Cash Equivalents, Beginning of Year9,799 6,838 
Cash and Cash Equivalents, End of Period$8,937 $8,658 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
8

Abbott Laboratories and Subsidiaries
Notes to the Condensed Consolidated Financial Statements
June 30, 2022
(Unaudited)

Note 1 — Basis of Presentation

The accompanying unaudited, condensed consolidated financial statements have been prepared pursuant to rules and regulations of the Securities and Exchange Commission and, therefore, do not include all information and footnote disclosures normally included in audited financial statements. However, in the opinion of management, all adjustments (which include only normal adjustments) necessary to present fairly the results of operations, financial position and cash flows have been made. It is suggested that these statements be read in conjunction with the financial statements included in Abbott’s Annual Report on Form 10-K for the year ended December 31, 2021. The condensed consolidated financial statements include the accounts of the parent company and subsidiaries, after elimination of intercompany transactions.

Note 2 — Revenue

Abbott’s revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The following tables provide detail by sales category:

Three Months Ended June 30, 2022Three Months Ended June 30, 2021
(in millions)U.S.Int’lTotalU.S.Int’lTotal
Established Pharmaceutical Products —
Key Emerging Markets$ $931 $931 $ $915 $915 
Other 292 292  265 265 
Total 1,223 1,223  1,180 1,180 
Nutritionals —    
Pediatric Nutritionals413 512 925 528 565 1,093 
Adult Nutritionals348 680 1,028 345 670 1,015 
Total761 1,192 1,953 873 1,235 2,108 
Diagnostics —     
Core Laboratory287 934 1,221 283 1,023 1,306 
Molecular71 141 212 94 196 290 
Point of Care101 38 139 97 40 137 
Rapid Diagnostics2,010 740 2,750 681 833 1,514 
Total2,469 1,853 4,322 1,155 2,092 3,247 
Medical Devices —    
Rhythm Management264 284 548 269 298 567 
Electrophysiology226 260 486 209 278 487 
Heart Failure179 62 241 168 59 227 
Vascular228 425 653 246 451 697 
Structural Heart207 233 440 191 231 422 
Neuromodulation157 40 197 166 44 210 
Diabetes Care 399 793 1,192 289 767 1,056 
Total1,660 2,097 3,757 1,538 2,128 3,666 
Other2  2 15 7 22 
Total$4,892 $6,365 $11,257 $3,581 $6,642 $10,223 
9

Abbott Laboratories and Subsidiaries
Notes to the Condensed Consolidated Financial Statements
June 30, 2022
(Unaudited)
Note 2 — Revenue (Continued)
Six Months Ended June 30, 2022Six Months Ended June 30, 2021
(in millions)U.S.Int’lTotal U.S.Int’lTotal
Established Pharmaceutical Products —
Key Emerging Markets$ $1,833 $1,833 $ $1,736 $1,736 
Other 537 537  514 514 
Total 2,370 2,370  2,250 2,250 
Nutritionals —    
Pediatric Nutritionals751 1,021 1,772 1,036 1,123 2,159 
Adult Nutritionals687 1,388 2,075 673 1,312 1,985 
Total1,438 2,409 3,847 1,709 2,435 4,144 
Diagnostics —
Core Laboratory555 1,850 2,405 554 1,934 2,488 
Molecular243 389 632 269 468 737 
Point of Care192 75 267 189 77 266 
Rapid Diagnostics4,220 2,084 6,304 1,784 1,986 3,770 
Total5,210 4,398 9,608 2,796 4,465 7,261 
Medical Devices —
Rhythm Management512 560 1,072 510 576 1,086 
Electrophysiology442